References
Citations
Katzenschlager R, et al. (2008). Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology, 71(7): 474–480.
Clarke CE, Moore AP (2007). Parkinson's disease, search date November 2006. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.
Stacy M, Factor S (2004). Rapid treatment of "off" episodes: Will this change Parkinson's disease therapy? Neurology, 62(6, Suppl 4): S1–S2.
Sofi F, et al. (2008). Adherence to Mediterranean diet and health status: Meta-analysis. BMJ. Published online September 11, 2008 (doi:10.1136/bmj.a1344).
Miyasaki JM, et al. (2002). Practice parameter: Initiation of treatment for Parkinson's disease: An evidence-based review. Neurology, 58(1): 11–17.
Samii A, et al. (2004). Parkinson's disease. Lancet, 363(9423): 1783–1793.
Shults CW, et al. (2002). Effects of coenzyme Q10 in early Parkinson disease. Archives of Neurology, 59(10): 1541–1550.
Storch A, et al. (2007). Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in Parkinson's disease. Archives of Neurology, 64(7): 938–944.
Other Works Consulted
Deuschl G, et al. (2006). A randomized trial of deep-brain stimulation for Parkinson's disease. New England Journal of Medicine, 355(9): 896–908.
Miyasaki JM, et al. (2006). Practice parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 66(7): 996–1002.
Pahwa R, et al. (2006). Practice parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 66(7): 983–985.
Siderowf A, Stern M (2003). Update on Parkinson disease. Annals of Internal Medicine, 138(8): 651–658.
Suchowersky O, et al. (2006). Practice parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 66(7): 968–975.
Suchowersky O, et al. (2006). Practice parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 66(7): 976–982.
